FDA clears Axilum Robotics ’ system for TMS positioning

(Image from Axilum Robotics) Strasbourg, France-based Axilum Robotics said today that it has received 510(k) clearance from FDA for its TMS-Cobot TS MV, indicated for the spatial positioning and orientation of the treatment coil of the MagVenture TMS Therapy system. Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique. Its approved and potential applications range from neuroscience research to the treatment of drug-resistant neurological or psychiatric diseases. Get the full story on our sister site, Medical Design & Outsourcing.   The post FDA clears Axilum Robotics’ system for TMS positioning appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Food & Drug Administration (FDA) Neuromodulation/Neurostimulation News Well Robotics axilumrobotics MagVenture Source Type: news